Similarly to PACAP, the neuroprotective effect of VIP has also been associated with its ability to block/prevent microglial activation and reduce the expression of pro-inflammatory mediators in a MPTP mouse model of PD (Delgado and Ganea 2003). The gene discussed is VIP; the disease is Parkinson disease.